Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

Private Market Index

IPO Stock Tracker

Solutions

Solutions

For Institutions

For Shareholders

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

Apexigen Stock

apexigen.comHealthcareFounded: 2010Funding to Date: $165.38MM

Apexigen is a clinical-stage biopharmaceutical company discovering and developing innovative immuno-oncology therapeutics generated by APXiMAB™, the Company’s proprietary antibody drug discovery platform.

Learn more about Apexigen IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Apexigen.

Register Today

Team

Management Team

Amy Wong

Vice President, Finance

Ovid Trifan MD

Chief Medical Officer

Xiaodong Yang Ph.D

Chief Executive Officer, President and Board Member

Mark Nevins

Vice President of Business Development

Frances Rena Bahjat Ph.D

Vice President of Discovery Research

Board Members

Herb Cross

William Rutter Ph.D

Dan Zabrowski Ph.D

Decheng Capital

George Lee Ph.D

Amkey Ventures

Xiaodong Yang Ph.D

Karen Liu Ph.D

3E Bioventures Capital

Kenneth Fong Ph.D

Kenson Ventures

Other companies like Apexigen in the Healthcare sector

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$4.26B

Sector

Last Round Est. Valuation

$809.52MM

Sector

Colossal Biosciences

Sector

Last Round Est. Valuation

$1.01B

Sector

Last Round Est. Valuation

$400.53MM

Sector

Sector

Last Round Est. Valuation

$1.53B

Sector

Last Round Est. Valuation

$396.01MM

Frequently Asked Questions

Updated on: Jun 8, 2023